Chemical modifications of sulfated xylofucan gave derivatives with regular structure.
Highly sulfated linear fucans inhibit clot formation and platelets aggregation.
Persulfated fucans potentiate thrombin and factor Xa inhibition by ATIII.
Docking study suggested formation of a ternary complex thrombin-ATIII-fucan.